Literature DB >> 26092229

GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.

Asmaa Gaber Abdou1, Marwa Mohammad Serag Eldien2, Daliah Elsakka2.   

Abstract

Glucose uptake is a key regulating step in glucose metabolism and is mediated by facilitative glucose transporters (GLUTs), and GLUT-1 is the predominant glucose transporter in many types of human cells. Cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) represent the most common skin cancer in Egypt. The present study aimed at evaluation of the pattern and distribution of GLUT-1 in cutaneous BCC (16 cases) and SCC (16 cases) by means of immunohistochemistry. GLUT-1 was expressed in all SCC (100%) and in 62.5% of BCC. Membranous pattern of GLUT-1 was seen in 62.5% of SCC and 31.25% of BCC. Positivity (P = .02) and percentage (P = .000) of GLUT-1 expression were in favor of SCC in comparison to BCC. The high percentage of GLUT-1 expression was associated with high grade in SCC (P = .03). The immunoreactivity for GLUT-1 was more in the periphery of malignant nests of SCC while it was more in the center of BCC nests. GLUT-1 is overexpressed in cutaneous non-melanoma skin cancer. Its expression in SCC is related to differentiation status, and its expression in BCC is intimately associated with squamous metaplastic areas.
© The Author(s) 2015.

Entities:  

Keywords:  GLUT-1; basal cell carcinoma; squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26092229     DOI: 10.1177/1066896915589968

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  6 in total

Review 1.  Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.

Authors:  Collin M Labak; Paul Y Wang; Rishab Arora; Maheedhara R Guda; Swapna Asuthkar; Andrew J Tsung; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

2.  Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT.

Authors:  Jianhong Zuo; Juan Wen; Mingsheng Lei; Meiling Wen; Sai Li; Xiu Lv; Zhaoyang Luo; Gebo Wen
Journal:  Med Oncol       Date:  2016-01-09       Impact factor: 3.064

3.  GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography.

Authors:  Omar Hasan Ali; Stefan Diem; Josef Aschwanden; Eva Markert; Abel-Jan Tasman; Joachim Mueller; Lukas Flatz
Journal:  JAAD Case Rep       Date:  2016-10-13

4.  CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.

Authors:  Juan Su; Tianyuan Gao; Minghao Jiang; Lisha Wu; Weiqi Zeng; Shuang Zhao; Cong Peng; Xiang Chen
Journal:  Oncotarget       Date:  2016-10-04

5.  Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma.

Authors:  Kai Che; Wenkai Han; Xiaokun Yang; Haitao Niu; Danxia Li; Shuxia Cui; Mingxin Zhang
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

6.  Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck.

Authors:  Mojgan Alaeddini; Shahroo Etemad-Moghadam
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.